|
|
Volumn 95, Issue 12, 2003, Pages 845-
|
|
First proteasome inhibitor approved for multiple myeloma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
PROTEASOME INHIBITOR;
STEROID;
THALIDOMIDE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
CYSTEINE PROTEINASE;
MULTIENZYME COMPLEX;
NEW DRUG;
PROTEASOME;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
ALLOTRANSPLANTATION;
CANCER CHEMOTHERAPY;
DRUG APPROVAL;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MULTIPLE MYELOMA;
NOTE;
PRIORITY JOURNAL;
UNITED STATES;
ARTICLE;
DRUG ANTAGONISM;
ENZYMOLOGY;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
CYSTEINE ENDOPEPTIDASES;
DRUG APPROVAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
MULTIENZYME COMPLEXES;
MULTIPLE MYELOMA;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PYRAZINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0345454817
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.12.845 Document Type: Note |
|
Times cited : (49)
|
|
References (0)
|